Griffin Rodgers

Molecular and Clinical Hematology Branch, NIDDK, United States of America

Griffin P Rodgers

Academic positions:
- Director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Chief of NIDDK's Clinical and Molecular Hematology Branch

Any industry positions (last five years):
None declared

Research interests:
Dr Rodgers and his collaborators had shown that hydroxyurea boosts the patients' levels of fetal and total hemoglobin thus alleviating their anemia, pain, and other debilitating symptoms. Now, he and his colleagues are doing studies to learn at what minimal dose erythropoietin, a costly medicine, can still be effective with hydroxyurea. With collaborators in the United States, China, Thailand, Israel, Greece, and Italy, Dr Rodgers is evaluating hydroxyurea's potential in thalassemia treatment. In 1993, Rodgers led a joint study by NIDDK, the National Heart, Lung, and Blood Institute, and the Johns Hopkins Medical School that showed how recombinant erythropoietin and an iron supplement could be used to boost hydroxyurea's effectiveness in sickle cell patients. In addition to this, he also works on the molecular basis of lineage-specific hematopietic differentiation.


Any other information:
- Arthur S. Flemming Award, an honor reserved for outstanding Federal employees with fewer than 15 years of service.
- Richard and Hinda Rosenthal Award of the American College of Physicians
- Meritorious Achievement Award of the National Medical Association
- Mastership American College of Physicians

At the NIH, Dr Rodgers has served on many committees, including:
- Board of Tutors for the Clinical Research Training Program
- Board of Governors of NIH's Clinical Center
- Institutional Review Board (IRB) for NIDDK
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, which protects the rights and welfare of people who are research subjects.

He is a member of the American Society of Hematology , the American Society of Clinical Investigation, and the Association of American Physicians, among others. He is the chair of the Hematology Subspecialty Board and is a member of the American Board of Internal Medicine Board of Directors.

Any competing interests declared are displayed with individual evaluations.

Section Head: Hematology > Anemias & Hypocellular Marrow Disorders (since 16 November 2005)

Griffin Rodgers is a Section Head for Anemias & Hypocellular Marrow Disorders, part of the HEMATOLOGY Faculty. The role of a Section Head is to work with their Co-Section Head(s) to divide the Section (sub-specialty area) into its component areas of research, nominate leaders in those areas as Faculty Members, and offer ongoing oversight of the content within their Section. They are not asked to evaluate articles, although we do, of course, welcome them.

Links

http://www2.niddk.nih.gov/Research/ScientificAreas/Hematology/